Opioid and dopamine genes interact to predict precision naltrexone response in alcohol use disorder: Interpretation misfires.
作者信息
Blum Kenneth, Lud Cadet Jean, Baron David, Badgaiyan Rajendra D, Gold Mark S
机构信息
Graduate College Western University Health Sciences, Pomona, CA USA.
Molecular Neuropsychiatry Research Branch, National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
J Syst Integr Neurosci. 2021 Mar 2;8:1.
Abstract
摘要
相似文献
1
2
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.阿片类药物和多巴胺基因相互作用，预测随机酒精使用障碍临床试验中纳曲酮的反应。
Alcohol Clin Exp Res. 2020 Oct;44(10):2084-2096. doi: 10.1111/acer.14431. Epub 2020 Sep 19.
3
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.促多巴胺调节剂（KB220PAM）与纳曲酮联合预防阿片类物质使用障碍复发的证据分析
EC Psychol Psychiatr. 2018 Aug;7(8):564-579. Epub 2018 Jul 30.
4
Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.纳曲酮对亚急性治疗和酒吧实验室范式中饮酒影响的修饰：阿片受体 mu 型 1（OPRM1）和多巴胺转运体（SLC6A3）基因的影响。
Alcohol Clin Exp Res. 2012 Nov;36(11):2000-7. doi: 10.1111/j.1530-0277.2012.01807.x. Epub 2012 May 2.
5
Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.用于酒精依赖药物治疗的阿片类拮抗剂——一项批判性综述。
Curr Drug Abuse Rev. 2008 Nov;1(3):280-91. doi: 10.2174/1874473710801030280.
6
[A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].[纳曲酮与胍法辛联合治疗阿片类成瘾者中多巴胺能和阿片样物质能基因的药物遗传学分析]
Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(11. Vyp. 2):36-48. doi: 10.17116/jnevro201611611236-48.
7
[Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].μ-阿片受体拮抗剂纳曲酮对酒精依赖的药理作用
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Oct;43(5):697-704.
8
μ-opioid receptors in the stimulation of mesolimbic dopamine activity by ethanol and morphine in Long-Evans rats: a delayed effect of ethanol.μ-阿片受体在乙醇和吗啡刺激长爪沙鼠中脑边缘多巴胺活性中的作用：乙醇的延迟效应。
Psychopharmacology (Berl). 2013 Aug;228(3):389-400. doi: 10.1007/s00213-013-3041-9. Epub 2013 Mar 16.
9
Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.系统回顾和荟萃分析 OPRM1 中 rs1799971 对纳曲酮治疗酒精使用障碍反应的调节作用。
Addiction. 2020 Aug;115(8):1426-1437. doi: 10.1111/add.14975. Epub 2020 Feb 11.
10
Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.德尔塔和κ阿片受体多态性影响纳曲酮对酒精主观反应的影响。
Pharmacol Biochem Behav. 2012 Dec;103(2):253-9. doi: 10.1016/j.pbb.2012.08.019. Epub 2012 Aug 27.
引用本文的文献
1
Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis.特邀专家意见——生物信息学与局限性指令，以助力采用遗传成瘾风险筛查并识别预测性奖赏失调：诱导多巴胺稳态所需的分析证据
Med Res Arch. 2023 Sep 14;11(8). doi: 10.18103/mra.v11i8.4211.
本文引用的文献
1
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.阿片类药物和多巴胺基因相互作用，预测随机酒精使用障碍临床试验中纳曲酮的反应。
Alcohol Clin Exp Res. 2020 Oct;44(10):2084-2096. doi: 10.1111/acer.14431. Epub 2020 Sep 19.
2
Alcoholics Anonymous and other 12-step programs for alcohol use disorder.戒酒互助会及其他针对酒精使用障碍的12步康复计划。
Cochrane Database Syst Rev. 2020 Mar 11;3(3):CD012880. doi: 10.1002/14651858.CD012880.pub2.
3
Medication-Assisted Treatment for Opioid-Use Disorder.阿片类物质使用障碍的药物辅助治疗。
Mayo Clin Proc. 2019 Oct;94(10):2072-2086. doi: 10.1016/j.mayocp.2019.03.029. Epub 2019 Sep 19.
4
Naltrexone: A History and Future Directions.纳曲酮：历史与未来发展方向。
Cerebrum. 2018 Sep 1;2018. eCollection 2018 Sep-Oct.
5
Association between the catechol-O-methyltransferase (COMT) ValMet polymorphism and motor behavior in healthy adults: A study review.儿茶酚-O-甲基转移酶（COMT）ValMet 多态性与健康成年人运动行为的关系：研究综述。
Brain Res Bull. 2019 Jan;144:223-232. doi: 10.1016/j.brainresbull.2018.11.002. Epub 2018 Nov 13.
6
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.遗传成瘾风险评分（GARS）™，一种阿片类药物依赖易感性的预测指标。
Front Biosci (Elite Ed). 2018 Jan 1;10(1):175-196. doi: 10.2741/e816.
7
Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder.μ阿片受体（OPRM1）和多巴胺D2受体（DRD2）的基因变异与精神分裂症患者而非双相情感障碍患者的吸烟差异有关。
Clin Schizophr Relat Psychoses. 2017 Spring;11(1):39-48. doi: 10.3371/1935-1232-11.1.39.
8
Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.OPRM1 A118G与酒精敏感性在年轻成年人中与静脉注射酒精自我给药的关联。
Addict Biol. 2016 Jan;21(1):125-35. doi: 10.1111/adb.12165. Epub 2014 Jul 20.
9
Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.多巴胺转运体基因基因型对体内多巴胺转运体功能的影响：一项荟萃分析。
Mol Psychiatry. 2014 Aug;19(8):880-9. doi: 10.1038/mp.2013.126. Epub 2013 Sep 24.
10
Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.阿片受体μ1基因（OPRM1）A118G多态性和ATP结合盒转运蛋白B1基因（ABCB1）C3435T多态性可能影响中国癌症疼痛患者的阿片类药物需求量。
Asian Pac J Cancer Prev. 2013;14(5):2937-43. doi: 10.7314/apjcp.2013.14.5.2937.
Zotero 插件